At some point, a weight loss plateau is expected
The presence of a well-structured healthcare system further supports the adoption of GLP-1 therapies, making Europe a promising market for future growth
For air travel, drops in their original pharmacy bottle are generally permitted in carry-on luggage
Int J Biol Sci 17(8):20502068 Bonfioli GB, Rodella L, Metra M, Vizzardi E (2024) GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
GLP-1 medications change more than just how fast food leaves the stomach - they also affect the way the gut moves between meals
Oral administration of PF-06882961 shows evidence of glucose-lowering in healthy human study participants PF-06882961 was selected as a candidate for clinical studies based on its in vitro and in vivo pharmacologic and disposition profile, including potent agonism of the GLP-1R, preclinical disposition attributes (e.g., low metabolic CL int in human hepatocytes), good safety margins versus the hERG channel (IC 50 = 4.3 M, Table S4) and broad panel screening (Table S8), and selectivity versus related class B GPCRs (Table S9)